| P50 | author | Eva Valdivia | Q56849767 |
| | Luis Rivas | Q58858959 |
| | Manuel Martínez Bueno | Q67287210 |
| | Mercedes Maqueda | Q86543151 |
| P2093 | author name string | Teresa Gárate | |
| | Rubén Cebrián | |
| | José María Saugar | |
| | María Ángeles Abengózar | |
| P2860 | cites work | Leishmaniasis worldwide and global estimates of its incidence | Q21134611 |
| | Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin | Q24675831 |
| | Bacteriocins as Potential Anticancer Agents | Q26776177 |
| | Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis | Q27011766 |
| | The Cyclic Antibacterial Peptide Enterocin AS-48: Isolation, Mode of Action, and Possible Food Applications | Q27021088 |
| | Structure of Bacteriocin AS-48: From Soluble State to Membrane Bound State | Q27642562 |
| | The bacteriocin AS-48 requires dimer dissociation followed by hydrophobic interactions with the membrane for antibacterial activity | Q27700049 |
| | Artemisinin Action and Resistance in Plasmodium falciparum | Q28276294 |
| | Bacteriocin AS-48 binding to model membranes and pore formation as revealed by coarse-grained simulations. | Q30645450 |
| | An enhanced method for the identification of Leishmania spp. using real-time polymerase chain reaction and sequence analysis of the 7SL RNA gene region | Q33795186 |
| | Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. | Q34134872 |
| | AS-48 bacteriocin: close to perfection. | Q34185754 |
| | Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody | Q34257759 |
| | Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment | Q34297640 |
| | Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense | Q34465626 |
| | Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action | Q35094496 |
| | The lipophosphoglycan of Leishmania parasites | Q35534721 |
| | Peptide AS-48: prototype of a new class of cyclic bacteriocins. | Q35950338 |
| | A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors. | Q36100083 |
| | Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. | Q36503914 |
| | Antineoplastic properties of bacteriocins: revisiting potential active agents. | Q37290884 |
| | Amphibian antimicrobial peptides and Protozoa: lessons from parasites | Q37338601 |
| | Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. | Q37370450 |
| | Combination therapy for visceral leishmaniasis | Q37698756 |
| | Are bacteriocins underexploited? Novel applications for old antimicrobials | Q37862317 |
| | Antimicrobial peptide action on parasites. | Q38015949 |
| | Trends in utilization of agro-industrial byproducts for production of bacteriocins and their biopreservative applications | Q38272181 |
| | Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes. | Q38542275 |
| | Bacteriocins and their position in the next wave of conventional antibiotics | Q38581198 |
| | Molecular mechanisms of membrane targeting antibiotics | Q38619583 |
| | Bacteriocins from lactic acid bacteria and their applications in meat and meat products | Q38818593 |
| | Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective | Q38882818 |
| | Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts. | Q38892717 |
| | Introduction: drug discovery and development for neglected diseases | Q39030231 |
| | Bacteriocins: Not Only Antibacterial Agents. | Q39294924 |
| | Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. | Q39565283 |
| | Characterization of the leishmanicidal activity of antimicrobial peptides | Q39749104 |
| | Effect of peptide AS-48 on Enterococcus faecalis subsp. liquefaciens S-47. | Q39819162 |
| | Purification, characterization, and lytic activity against Naegleria fowleri of two amoebicins produced by Bacillus licheniformis A12. | Q39857489 |
| | Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies | Q39864870 |
| | Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. | Q39938501 |
| | Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes | Q40622211 |
| | Pinensins: the first antifungal lantibiotics | Q40695785 |
| | Developmental life cycle of Leishmania--cultivation and characterization of cultured extracellular amastigotes. | Q40891267 |
| | Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. | Q41708032 |
| | Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression | Q42780516 |
| | Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria | Q43024258 |
| | Effect of bacterial metabolites on microsporidian Nosema ceranae and on its host Apis mellifera | Q43063764 |
| | New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II. | Q43175595 |
| | Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells | Q44148138 |
| | Antifungal properties of durancins isolated from Enterococcus durans A5-11 and of its synthetic fragments. | Q45914768 |
| | Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. | Q46429094 |
| | Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles | Q46496694 |
| | Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and gram-negative bacteria and other organisms. | Q46727243 |
| | Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin | Q48033055 |
| | A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32. | Q50102309 |
| | Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. | Q50497963 |
| | Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. | Q50735455 |
| | The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation. | Q50744476 |
| | Total Synthesis of Circular Bacteriocins by Butelase 1. | Q50851179 |
| | Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. | Q52466989 |
| | Potential Applications of the Cyclic Peptide Enterocin AS-48 in the Preservation of Vegetable Foods and Beverages | Q56831789 |
| | Influence of Physico-Chemical Factors on the Oligomerization and Biological Activity of Bacteriocin AS-48 | Q56831902 |
| | Monolayer Characteristics of Bacteriocin AS-48, pH Effect and Interactions with Dipalmitoyl Phosphatidic Acid at the Air–Water Interface | Q56831910 |
| | Fatty acid composition modulates sensitivity of Legionella pneumophila to warnericin RK, an antimicrobial peptide | Q57954143 |
| | Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes | Q60222341 |
| | Microcin J25-Ga induces apoptosis in mammalian cells by inhibiting mitochondrial RNA-polymerase | Q61247378 |
| | The plasma membrane electrical gradient (membrane potential) in Leishmania donovani promastigotes and amastigotes | Q68054780 |
| | Antimycobacterial activity of bacteriocins and their complexes with liposomes | Q79906116 |
| | Growing insights into the safety of bacteriocins: the case of enterocin S37 | Q82235217 |
| | An 'Upp'-turn in bacteriocin receptor identification | Q87841208 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents | |
| P478 | volume | 61 | |